tirzepatide safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database How Tirzepatide Helps Lose Weight

[2] Zepbound is specifically indicated for adults with a BMI 30 kg/m (obesity) or 27 kg/m (overweight) with at least one weight-related comorbidity, as an adjunct to reduced-calorie diet and increased physical activity

A medical history identifying two or more symptoms consistent with histamine intolerance A medication review to identify drugs that may inhibit DAO activity or affect mast cells An evaluation for other potential causes, such as gastrointestinal conditions, food allergies, or mast cell disorders, while still considering histamine intolerance as a possible comorbidity Serum DAO measurement An oral histamine challenge test, typically performed in a hospital because of the lack of a standardized safe dose and the risk of adverse effects

Monitor blood sugar levels , as discontinuation may cause fluctuations

This is a drug interaction that directly contributes to fatigue in people on combination therapy

Taking it alongside oral medicines, like insulin glargine or other diabetes drugs, may affect blood sugar levels